Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Influenza-specific effector memory B cells predict long-lived antibody responses to vaccination in humans [scRNA-Seq]

ABSTRACT: Influenza-specific effector memory B cells predict long-lived antibody responses to vaccination in humans [scRNA-Seq]

PROVIDER: PRJNA923706 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23078772_1.fastq.gz	Fastqsanger.gz
	SRR23078772_2.fastq.gz	Fastqsanger.gz
	SRR23078773_1.fastq.gz	Fastqsanger.gz
	SRR23078773_2.fastq.gz	Fastqsanger.gz
	SRR23078774_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Influenza-specific effector memory B cells predict long-lived antibody responses to vaccination in humans

Project description:Influenza-specific effector memory B cells predict long-lived antibody responses to vaccination in humans

| PRJNA922173 | ENA

Influenza-specific effector memory B cells predict long-lived antibody responses to vaccination in humans [Rep-Seq]

Project description:Influenza-specific effector memory B cells predict long-lived antibody responses to vaccination in humans [Rep-Seq]

| PRJNA922176 | ENA

Influenza-specific effector memory B cells predict long-lived antibody responses to vaccination in humans

Project description:This SuperSeries is composed of the SubSeries listed below.

2023-03-01 | GSE222476 | GEO

Influenza-specific effector memory B cells predict long-lived antibody responses to vaccination in humans [scRNA-Seq]

Project description:BCR repertoire sequencing data from influenza vaccinated subjects

2023-03-01 | GSE222888 | GEO

Influenza-specific effector memory B cells predict long-lived antibody responses to vaccination in humans [Rep-Seq]

Project description:BCR repertoire sequencing data from influenza vaccinated subjects.

2023-03-01 | GSE222474 | GEO

Affinity maturation broadens influenza vaccine-induced antibody responses in humans [bcr]

Project description:Influenza virus vaccination remains the best strategy for combating virus infection, but vaccine efficacy is highly variable. An ideal influenza vaccine must have two attributes: one, it should be capable of inducing broadly cross-reactive antibodies that can neutralize diverse influenza virus strains; and two, it must induce long-lived antibody responses to maintain protective immunity for extended periods. Germinal center (GC) reactions are the major sites where diversification and affinity maturation of B cells occur. Whether a persistent GC response could expand the breadth of responding B cell clones following influenza vaccination in humans remains unknown. Here, we show that influenza virus vaccine-specific GC B cells persist for over nine weeks post vaccination in two out of seven individuals. These late vaccine-specific GC B cells exhibited increased somatic hypermutation (SHM) of their B cell receptors compared to early vaccine-specific GC B cells. After re-immunization with seasonal influenza virus vaccine, individuals with a persistent GC engaged vaccine-specific plasmablasts (PBs) with higher SHM frequency. Tracking the maturation of three clonally related GC B cell lineages over time revealed that late GC B cells had receptors that recognized and neutralized heterologous influenza virus strains. Thus, SHM induced by persistent GCs can broaden the antibody response to influenza virus vaccination. This indicates that seasonal influenza virus vaccination in humans can induce broadly cross-reactive antibodies that target diverse influenza virus strains.

2024-06-13 | GSE211869 | GEO

Affinity maturation broadens influenza vaccine-induced antibody responses in humans [gex]

2024-06-13 | GSE211865 | GEO

CHIKV VLP Vaccination in Humans induced broadly neutralizing antibodies

Project description:VLP Vaccination in humans induced antigen-specific B cells with broad reactivity and protection in mouse models of infection

2023-03-31 | GSE218843 | GEO

Transcriptional responses to Prevnar-13 vaccination in humans

Project description:Transcriptional responses to Prevnar-13 vaccination in humans

| PRJNA1269966 | ENA

Clinical study on the plasma and urine proteomics and antibody titers after COVID-19 vaccination

Project description:To find baseline markers that accurately predict vaccine reactivity and evaluate the correlation between baseline blood and urine proteomics and antibody titers after COVID-19 vaccination.

2023-11-09 | PXD036380 |

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data